Skip to content

3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization

3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03164629
Enrollment
50
Registered
2017-05-23
Start date
2017-04-17
Completion date
2018-10-19
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enlarged Prostate

Keywords

BPH, Lower Urinary Track Infection, Urine Retention

Brief summary

The purpose of this research study is to learn about how cone-beam Computerized Tomography scans (X-ray images taken from different angles) work together with an embolization guidance software (helps the doctor see the arteries that feed the prostate)to find and see arteries in the prostate.

Interventions

DEVICEcone-beam CT 3D Emboguide

cone-beam CT with Embolization Guidance software (Emboguide) to identify prostatic arteries and assist endovascular navigation, by projecting a 3D road map of prostatic arteries on live fluoroscopy, in order to differentiate them from non-target vessels.

Sponsors

Siemens Corporation, Corporate Technology
CollaboratorINDUSTRY
University of Miami
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
50 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Patient is age 50 to 79, inclusive * Patients undergoing Prostate artery embolization for BPH or urinary retention -Patient has signed informed consent.

Exclusion criteria

* Patients with biopsy proven prostate cancer * Patient weight of \>300 lbs

Design outcomes

Primary

MeasureTime frameDescription
Time for Prostatic Artery Catheterizationhour 2For the cases using Emboguide this will be measured as the time from which the Emboguide is displayed on the live fluoroscopy to the time of prostatic artery catheterization. Emboguide display is in addition to the angiogram roadmap display. For the control cases this will be measured as the time from which the angiogram is displayed on the live fluoroscopy to the time of prostatic artery catheterization.

Countries

United States

Participant flow

Participants by arm

ArmCount
3D Angiogram + Emboguide
Participants will receive cone-beam CT 3D Emboguide: cone-beam CT with Embolization Guidance software (Emboguide) to identify prostatic arteries and assist endovascular navigation, by projecting a 3D road map of prostatic arteries on live fluoroscopy, in order to differentiate them from non-target vessels.
25
No 3D Angiogram + Emboguide
Embolization will be guided by a standard of care CT.
25
Total50

Baseline characteristics

Characteristic3D Angiogram + EmboguideNo 3D Angiogram + EmboguideTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
11 Participants13 Participants24 Participants
Age, Categorical
Between 18 and 65 years
14 Participants12 Participants26 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
25 Participants25 Participants50 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

Time for Prostatic Artery Catheterization

For the cases using Emboguide this will be measured as the time from which the Emboguide is displayed on the live fluoroscopy to the time of prostatic artery catheterization. Emboguide display is in addition to the angiogram roadmap display. For the control cases this will be measured as the time from which the angiogram is displayed on the live fluoroscopy to the time of prostatic artery catheterization.

Time frame: hour 2

Population: at times unable to catheterize the participants arteries

ArmMeasureGroupValue (MEAN)Dispersion
3D Angiogram + EmboguideTime for Prostatic Artery CatheterizationRight Artery273.40 secondsStandard Deviation 406.64
3D Angiogram + EmboguideTime for Prostatic Artery CatheterizationLeft Artery206.38 secondsStandard Deviation 228.96
No 3D Angiogram + EmboguideTime for Prostatic Artery CatheterizationRight Artery181.71 secondsStandard Deviation 185.11
No 3D Angiogram + EmboguideTime for Prostatic Artery CatheterizationLeft Artery155.96 secondsStandard Deviation 216.32

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026